PhaseBio Pharmaceuticals, Inc. announced the appointment of Michael B. York as Vice President of Corporate Development and Commercial Strategy. Mr. York is based in PhaseBio’s San Diego, CA office. Mr. York joins PhaseBio from Orexigen Therapeutics, Inc., where, as Vice President, Global Business Development and Alliance Management, he led global business development activities to license Orexigen’s assets and to manage alliance partners, including overseeing transactions for 68 countries with nine multi-national and regional partners. Prior to Orexigen, Mr. York was President and Chief Executive Officer of Senté Labs, Inc.